{
    "Trade/Device Name(s)": [
        "ACE Alkaline Phosphatase Reagent",
        "ACE Amylase Reagent",
        "ACE ALT Reagent",
        "ACE AST Reagent"
    ],
    "Submitter Information": "Alfa Wassermann Diagnostic Technologies, LLC",
    "510(k) Number": "K131351",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113253",
        "K931786",
        "K930104",
        "K113436",
        "K113382"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CJE",
        "CIJ",
        "CKA",
        "CIT"
    ],
    "Summary Letter Date": "July 8, 2013",
    "Summary Letter Received Date": "July 9, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1050",
        "21 CFR 862.1070",
        "21 CFR 862.1030",
        "21 CFR 862.1100"
    ],
    "Regulation Name(s)": [
        "Alkaline phosphatase or isoenzymes test system",
        "Amylase test system",
        "Alanine aminotransferase (ALT/SGPT) test system",
        "Aspartate aminotransferase (AST/SGOT) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Alkaline phosphatase",
        "Amylase",
        "Alanine aminotransferase",
        "Aspartate aminotransferase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium heparin plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Lithium heparin plasma tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ACE Clinical Chemistry System",
        "ACE Alera Clinical Chemistry System",
        "ACE Axcel Clinical Chemistry System"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric"
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Alfa Wassermann ACE Clinical Chemistry Reagents for quantification of ALP, Amylase, ALT, and AST using photometric assays",
    "Indications for Use Summary": "Intended for quantitative determination of alkaline phosphatase, \u03b1-amylase, alanine aminotransferase, and aspartate aminotransferase activity in serum and lithium heparin plasma using ACE, ACE Alera, and ACE Axcel Clinical Chemistry Systems, aiding in diagnosis and treatment of liver, bone, parathyroid, intestinal diseases, pancreatitis, and heart diseases; for use in clinical laboratories and physician office laboratories, for in vitro diagnostic use only",
    "fda_folder": "Clinical Chemistry"
}